Table 2. Comparison of clinical characteristics of patients with different prognosis groups.
| Characteristics | Total | Good curative effect | Poor curative effect | P-value |
|---|---|---|---|---|
| Number | 705 | 546 (77.45%) | 159 (22.55%) | |
| Continuous variables with normal distribution | ||||
| Age | 45.02 ± 11.46 | 44.87 ± 10.86 | 45.53 ± 13.36 | 0.573 |
| Hg | 139.61 ± 16.04 | 139.44 ± 16.36 | 140.19 ± 14.92 | 0.609 |
| ALB | 46.20 ± 3.17 | 46.26 ± 3.27 | 45.97 ± 2.77 | 0.279 |
| PLT | 261.95 ± 63.81 | 265.36 ± 63.62 | 251.20 ± 63.25 | 0.0141 |
| PDW | 12.32 ± 1.65 | 12.20 ± 2.12 | 12.48 ± 2.06 | 0.135 |
| MPV | 10.49 ± 0.75 | 10.47 ± 0.92 | 10.58 ± 0.91 | 0.177 |
| RDW | 13.37 ± 2.73 | 13.59 ± 5.72 | 13.11 ± 1.26 | 0.293 |
| BMI | 25.44 ± 3.19 | 25.45 ± 5.04 | 25.42 ± 4.21 | 0.945 |
| Continuous variables with skewed distribution | ||||
| NEUT | 3.99 (3.00–5.23) | 3.85 (2.95–3.85) | 4.47 (3.16–5.83) | 0.0081 |
| LBC | 2.02 (1.57–2.92) | 1.95 (1.54–2.65) | 2.06 (1.51–6.15) | 0.119 |
| PCT | 0.28 (0.24–0.33) | 0.28 (0.24–0.33) | 0.29 (0.23–0.33) | 0.159 |
| NLR | 2.11 (1.56–2.31) | 2.11 (1.54–3.32) | 2.11 (1.71–2.19) | 0.448 |
| Categorical variables | ||||
| Gender | 0.781 | |||
| Male | 211 | 162 (76.8%) | 49 (23.2%) | |
| Female | 494 | 384 (77.7%) | 110 (22.3%) | |
| Variants | 0.674 | |||
| Yes | 48 | 36 (75.0%) | 12 (25.0%) | |
| No | 657 | 510 (77.6%) | 147 (22.4%) | |
| PLT subgroups | 0.0011 | |||
| 1 | 550 | 411 (74.7%) | 139 (25.3%) | |
| 2 | 155 | 135 (87.1%) | 20 (12.9%) | |
| NLR subgroups | 0.069 | |||
| 1 | 505 | 382 (75.6%) | 123 (24.4%) | |
| 2 | 200 | 164 (82.0%) | 36 (18.0%) | |
| T stage | 0.1102 | |||
| 1a | 207 | 170 (82.1%) | 37 (17.9%) | |
| 1b | 273 | 210 (76.9%) | 63 (23.1%) | |
| 2 | 51 | 42 (82.4%) | 9 (17.6%) | |
| 3 | 99 | 71 (71.7%) | 28 (28.3%) | |
| 4a | 58 | 43 (74.1%) | 15 (25.9%) | |
| 4b | 17 | 10 (58.8%) | 7 (41.2%) | |
| N stage | 0.168 | |||
| 0 | 99 | 82 (82.8%) | 17 (17.2%) | |
| 1a | 369 | 289 (78.3%) | 80 (21.7%) | |
| 1b | 237 | 175 (73.8%) | 62 (26.2%) | |
| COR-BMI | 0.0471,2 | |||
| 1 | 9 | 6 (66.7%) | 3 (33.3%) | 0.3862,3 |
| 2 | 371 | 300 (80.9%) | 71 (19.1%) | 0.7033,4 |
| 3 | 325 | 240 (73.8%) | 85 (26.2%) | 0.0275 |
3,4,5Adjusted the significance level according to Bonferroni’s method. P<0.017 is considered significant.
1
P<0.05.
2
Fisher’s exact test.
3
Differences between COR-BMI 1 and 2.
4
Differences between COR-BMI 1 and 3.
5
Differences between COR-BMI 2 and 3.